Navigation Links
Case Management Cost-Effective Way to Cut Heart Risks
Date:8/29/2007

California study shows such visits with patients reduced risk by 10% and also cut costs

WEDNESDAY, Aug. 29 (HealthDay News) -- Case management provided a cost-effective way of reducing patients' overall risk of heart disease by about 10 percent, according to a study by researchers at Stanford University in California.

In case management, specially trained health professionals such as nurses and dietitians help patients manage chronic conditions on a long-term basis. Case managers handle many of the patient counseling and tracking roles normally done by doctors.

"Case management makes a lot of sense when it comes to chronic disease, because you need to have constant contact with patients to pick up on any problems before they get worse," study lead author Dr. Randall Stafford, an associate professor of medicine at the Stanford Prevention Research Center, said in a prepared statement.

This 17-month study included 341 patients randomly assigned to receive either primary care alone or primary care augmented by case management visits. Patients in the case management group had an average of 14 hours of contact with their case manager during the study.

During visits that lasted 40 minutes to 60 minutes each, patients and case managers reviewed the patient's progress on lifestyle and medication goals and developed a plan for the next few weeks.

At the start of the study, all the participants had a 10 percent to 15 percent risk of suffering a heart attack or severe heart disease over the next 10 years. After the study, the researchers estimated that patients in the case management group had lowered their risk by about 1.6 percent -- about a 10 percent reduction.

The overall cost of the case management visits was about $1,250 per patient, which is about the same as six regular office visits to a primary care doctor. That's a small amount to reduce the risk of a heart attack, which can result in more tha
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. New Modality in Migraine Management
2. Self-Management Program Beneficial for Back Pain
3. Self-Management Program Beneficial for Back Pain
4. Disease Management Programs – Effective for Heart Patient
5. Effective Management Of Heart Patients
6. New advance in prostate cancer management
7. Gastrin, Much More Than The Weight Management Hormone
8. Medical Management Now Available For Miscarriage
9. Early Awareness About Weight Management Needed To Tackle Lifelong Obesity
10. Exercise For Effective Pain Management In Old People
11. Glimepiride in the medical management of Type 2 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)..., Critical legislation would strengthen Medicare...RK, Nov. 8 SUMMARY: Y...s passed critical health care reform legislation t...discrimination by insurance companies that prices ...erage. ,, The Affordable Health Care for Amer...
(Date:11/8/2009)...oring pain now can take you out of the game later,...ay News) -- Foot injuries are the talk of the NFL ...Eli Manning and running back Willie Parker. , O...tion and American Academy of Podiatric Sports Medi...et when they play fall sports like football and la...
(Date:11/8/2009)... 3D Global Solutions is plea...gram managing the proposal effort for ReSound who ...Digital Hearing Aid contract. The award includes n...Department of Defense and other federal agencies. ...vember 8, 2009 -- 3D Global Solutions is pleased t...
(Date:11/8/2009)..., "One victory does not mean the battle is won,"... 7 In a vote of 240-194...inski-Smith Amendment to prohibit abortion mandate.... ,, Americans United for Life Action President... this amendment is a victory for the pro-life Amer...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 T...Director, Operation Rescue Insurrecta Nex. ,, ...ry have been fighting to keep child-killing by abo..., Mr. Terry states: "This is a great first step to...t we have a lot of fighting ahead of us. Our rejoi...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:Rx for Fall Foot Injuries 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2
...uspected SARS case in six months may have the coro... it was waiting for more results to come in.// ... contracted the SARS coronavirus," Xu Ruiheng, dep...g. A 32-year-old television worker is suspe...
... than 5 million service men and women before and a...reducing an alarmingly high rate of suicide seen a...had been particularly higher for black and white m...osocial problems, with an emphasis on removing the...
...elief that infants' brains don't divide into left-...tudy finds the brain's left hemisphere plays the l...s beginning almost immediately after birth. Re...ime fMRI has been used to study infants. It is a n...
...archers say common cold may help fight cancer. Re...neer the common cold virus so that //it kills canc... They did this by modifying one gene, so the virus.... Specialists say, “When the virus infects cells, ...
...hma have long recommended inhaled corticosteroid (... persistent forms of the condition.But reports abo...ple -- including parents of asthmatic children -- ...problems. Now leading scientists hope to put t...
...peutic option for patients with complicated type 1...e has been controversial. // Now, a new study f...pear to have worse survival than patients on the t... had or need a kidney transplant. However, in the ...
Other Medicine News:Health News:New Technique to Study Infants Brain. 2Health News:Benefits and Risks of Asthma Treatment Questioned 2Health News:Pancreas Transplant for Diabetics 2
(Date:11/6/2009)...all/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ), ... of small-molecule therapeutics for the treatment ...HIV), today reported recent accomplishments and fi...ths ended September 30, 2009. ,, (Logo: http... ) ,, "Since our last quarterly update, we have...
(Date:11/6/2009)... Chimerix, Inc., a biopharmaceutic...erapeutics to address life-threatening diseases, p...,s lead antiviral compound, CMX001, to the World H...urity Initiative (GHSI). CMX001 is a broad-spectr...nt of smallpox, as well as other serious viral inf...
(Date:11/6/2009)...l/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX...biopharmaceutical company developing human vaccine...ency Virus) and other infectious agents, today ann...d provided an operational update. ,, Robert McN... commented, "We are pleased with our progress duri...
Breaking Medicine Technology:Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster 12804 1Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster 12804 2HIV Testing Day Set for Saturday in U S 50162 1Bausch 26 Lomb Kicks Off U S Consumer Online Marketing Campaign for SofLens 28R 29 Daily Disposable Contact Lenses 50158 1Bausch 26 Lomb Kicks Off U S Consumer Online Marketing Campaign for SofLens 28R 29 Daily Disposable Contact Lenses 50158 2
...n-Probe Incorporated,(Nasdaq: GPRO ) has submitte... supplemental regulatory application for the addit...reen donated blood for the hepatitis B,virus (HBV)...e assay to,screen donated blood for HIV-1 and the ...y is seeking approval to use the assay to screen f...
...1 Alfacell Corporation,(Nasdaq: ACEL ) today ann...,the 5th Cancer Drug Research & Development confer...ys impacted by ONCONASE stimulated,intracellular e... malignant,mesothelioma cell lines. Data presented...ll human cancer cells in cell culture and murine m...
Other Medicine Technology:Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 2Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 3Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 4Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R) 2Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R) 3
... frames are designed with the safety and comfort o...RS-520 (also called SF-6) leaded glass, the indust...enses meet standards, as set for optical clarity, ...tion. ,While our eyewear is protecting your eyes...
Radiation Protection Goggles
Ultralight Jarrod Goggles
QualCraft™ Euro Lite
Medicine Products: